Cervomed Inc <CRVO.O>: Canaccord Genuity cuts target price to $18 from $27
CRVO•Related News

ANI Pharmaceuticals Inc <ANIP.O>: Canaccord Genuity cuts target price to $90 from $91
ANIP•

Seadrill Q2 revenue tops estimates on increased operating days
SDRL•

Kestra Medical Technologies, Ltd. <KMTS.O>: JPMorgan initiates coverage with overweight rating; price target $30
KMTS•

Loar Holdings Inc. <LOAR.N>: Jefferies raises target price to $88 from $75
LOAR•

Redwire Corporation <RDW.N>: Jefferies Cuts Target Price to $15 from $24
RDW•